Taralkumar Arvindbhai Naik

[Taralkumar Arvindbhai Naik @taral123]

Nuformix PLC - Confirmation of European Orphan Drug Designation #NFX @NuformixPlc https://t.co/nQm2nqmef0 #voxmarkets undefined #nfx

[Taralkumar Arvindbhai Naik @taral123]

Nuformix PLC - NXP002 Update #NFX @NuformixPlc https://t.co/HcQeZGH9Ff #voxmarkets undefined #nfx

[Taralkumar Arvindbhai Naik @taral123]

@landrcl

[Taralkumar Arvindbhai Naik @taral123]

#Leicester

[Taralkumar Arvindbhai Naik @taral123]

@hinckandbos_bc

[Taralkumar Arvindbhai Naik @taral123]

@AlexGoldberg_ Not coming live today sir.

[Taralkumar Arvindbhai Naik @taral123]

@Woodywudpeck Looks like these are 35m warrents issue in April last year.

[DirectorsTalk @DirectorsTalk]

Nuformix plc Official Decision to Grant from the Japanese Patent Office

read Here: https://t.co/S5Bttz0wwv

#NFX #Nuformix #Pharmaceuticals #Therapeutics #Oncology #Fibrosis #DrugRepurposing #NXP001 #NXP002 #Investing @IFCAdvisory #RNS #Stocks

[Francis Alexander @silent_trades]

Nuformix excited as it moves focus to NXP002 and NXP004 programmes

Watch Here: https://t.co/bEuRLe57Bk

#NFX #Nuformix #Pharmaceuticals #Therapeutics #Oncology #Fibrosis #DrugRepurposing #NXP001 #NXP002 #Investing @IFCAdvisory #RNS #Stocks

[DirectorsTalk @DirectorsTalk]

Nuformix receives new NXP001 development milestone payments in updated Oxilio agreement

Read More: https://t.co/I0CqlMuBOn

#NFX #Nuformix #Pharmaceuticals #Therapeutics #Oncology #Fibrosis #DrugRepurposing #NXP001 #NXP002 #Investing @IFCAdvisory #RNS #Stocks

[Nuformix plc @NuformixPlc]

An incredibly productive and educational #ERS2023 so far, making new connections and gaining new insights! Inhalation and combination therapies in the treatment of #IPF have to be part of the solution towards long term safety and efficacy in lung fibrosis #NFX #NX002

[Taralkumar Arvindbhai Naik @taral123]

@AimBser What set up you are using if you don’t mind sharing please.

[CityGirl @CityGirlTrader]

Fantastic presentation on the future prospects of @NuformixPlc #NFX - they now have the data which leads to licencing partnerships.

https://t.co/blIxX8hwWV

[CityGirl @CityGirlTrader]

Shows what kinds of deals are out there right now...

#NFX mcap 2mill, has all ducks lined up and ready for licencing. Dyor

@AstraZeneca
@Novartis
#IPF #vicore #puretech #boehringeringelheim #roche #shionogi #az #astrazeneca

@NuformixPlc

https://t.co/PMpF4O6sXA

[Nuformix plc @NuformixPlc]

Another impressive regulatory approval for Lynparza in prostate cancer announced today https://t.co/VVfOqs7nnQ #NFX #NXP004 #lynparza

[Nuformix plc @NuformixPlc]

We get a lot of questions on the subiect of what causes #IPF this graphic from @PFFORG is a great summary. There will be a chance to ask #NuformixPIc more questions very soon #NFX #NXP002 #curePF

[Taralkumar Arvindbhai Naik @taral123]

#nfx Nuformix PLC - Change of Auditor #NFX @NuformixPlc https://t.co/xwv6SkwzrE #voxmarkets undefined

[CityGirl @CityGirlTrader]

Word getting out that @NuformixPlc is already undertaking talks for licencing. Dyor. Low entry here...

[Nuformix plc @NuformixPlc]

Prof. Luca Richeldi stating yesterday at #ATS2023 that inhalation is part of a brighter future for #IPF treatment #NXP002 #NFX